期刊
ONCOTARGETS AND THERAPY
卷 13, 期 -, 页码 12881-12891出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/OTT.S280690
关键词
APOC1; cervical cancer; progression; prognosis
资金
- National Natural Science Foundation of China [81672560, 81772773, 81302275]
- Jiangsu Provincial Medical Youth Talent [QNRC2016753]
- Suzhou Clinical Key Technology Project [LCZX201705]
- Gusu Medical Youth Talent [GSWS2019034]
- Project of Jiangsu Provincial Maternal and Child Health Association [FYX201709]
- Suzhou Clinical Trial Project [SLT201912]
Background: Previous reports showed that APOC1 was associated with several cancers but the function of APOC1 in cervical cancer was unknown. This study aimed to investigate the clinical effect and function of APOC1 in cervical cancer. Materials and Methods: In this study, the relative expression of APOC1 in cervical cancer was detected by RT-qPCR. In order to determine the cell proliferation and migration and invading ability and apoptosis more accurately, we used CCK8 assay, Edu assay, wound healing assay, migration and invasion assay, flow cytometry assay, co-immunoprecipitation, proteomics and Western blot by silencing and overexpressing APOC1, respectively. The role of APOC1 on tumor progression was explored in vitro and vivo. Results: The relative expression of APOC1 in cervical cancer tissues was up-regulated (P<0.05). In cervical cancer cell lines, silencing of APOC1 restrained cell progression and EMT, while over-expression of APOC1 accelerated cell progression and EMT in vivo and vitro (P<0.05). Conclusion: APOC1 acts as an oncogene in cervical cancers and knockdown of APOC1 inhibited cervical cancer cells growth in vitro and in vivo. There is a close relationship between the relative expression of APOC1 and clinical outcome in cervical cancer patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据